These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 29437969)

  • 1. Monoclonal Antibodies against Occludin Completely Prevented Hepatitis C Virus Infection in a Mouse Model.
    Shimizu Y; Shirasago Y; Kondoh M; Suzuki T; Wakita T; Hanada K; Yagi K; Fukasawa M
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29437969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies against extracellular domains of claudin-1 block hepatitis C virus infection in a mouse model.
    Fukasawa M; Nagase S; Shirasago Y; Iida M; Yamashita M; Endo K; Yagi K; Suzuki T; Wakita T; Hanada K; Kuniyasu H; Kondoh M
    J Virol; 2015 May; 89(9):4866-79. PubMed ID: 25673725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human-rat chimeric anti-occludin monoclonal antibodies inhibit hepatitis C virus infection.
    Shimizu Y; Yoneda K; Shirasago Y; Suzuki T; Tada M; Ishii-Watabe A; Sugiyama K; Suzuki T; Wakita T; Yagi K; Kondoh M; Fukasawa M
    Biochem Biophys Res Commun; 2019 Jun; 514(3):785-790. PubMed ID: 31079928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma.
    Sekhar V; Pollicino T; Diaz G; Engle RE; Alayli F; Melis M; Kabat J; Tice A; Pomerenke A; Altan-Bonnet N; Zamboni F; Lusso P; Emerson SU; Farci P
    PLoS Pathog; 2018 Mar; 14(3):e1006916. PubMed ID: 29538454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies.
    Sourisseau M; Michta ML; Zony C; Israelow B; Hopcraft SE; Narbus CM; Parra Martín A; Evans MJ
    PLoS Pathog; 2013 Mar; 9(3):e1003244. PubMed ID: 23555257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo.
    Ding Q; von Schaewen M; Hrebikova G; Heller B; Sandmann L; Plaas M; Ploss A
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of anti-claudin-1 antibodies as candidate therapeutics against hepatitis C virus.
    Yamashita M; Iida M; Tada M; Shirasago Y; Fukasawa M; Nagase S; Watari A; Ishii-Watabe A; Yagi K; Kondoh M
    J Pharmacol Exp Ther; 2015 Apr; 353(1):112-8. PubMed ID: 25628391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.
    Ploss A; Evans MJ; Gaysinskaya VA; Panis M; You H; de Jong YP; Rice CM
    Nature; 2009 Feb; 457(7231):882-6. PubMed ID: 19182773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occludin-binding single-chain variable fragment and antigen-binding fragment antibodies prevent hepatitis C virus infection.
    Shimizu Y; Shinoda T; Shirasago Y; Kondoh M; Shinya N; Hanada K; Yagi K; Suzuki T; Wakita T; Kimura-Someya T; Shirouzu M; Fukasawa M
    FEBS Lett; 2021 Jan; 595(2):220-229. PubMed ID: 33113151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species-specific regions of occludin required by hepatitis C virus for cell entry.
    Michta ML; Hopcraft SE; Narbus CM; Kratovac Z; Israelow B; Sourisseau M; Evans MJ
    J Virol; 2010 Nov; 84(22):11696-708. PubMed ID: 20844048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel occludin-targeting monoclonal antibody prevents hepatitis C virus infection
    Okai K; Ichikawa-Tomikawa N; Saito AC; Watabe T; Sugimoto K; Fujita D; Ono C; Fukuhara T; Matsuura Y; Ohira H; Chiba H
    Oncotarget; 2018 Mar; 9(24):16588-16598. PubMed ID: 29682171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro.
    Fénéant L; Ghosn J; Fouquet B; Helle F; Belouzard S; Vausselin T; Séron K; Delfraissy JF; Dubuisson J; Misrahi M; Cocquerel L
    PLoS One; 2015; 10(11):e0142539. PubMed ID: 26561856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes.
    Fofana I; Krieger SE; Grunert F; Glauben S; Xiao F; Fafi-Kremer S; Soulier E; Royer C; Thumann C; Mee CJ; McKeating JA; Dragic T; Pessaux P; Stoll-Keller F; Schuster C; Thompson J; Baumert TF
    Gastroenterology; 2010 Sep; 139(3):953-64, 964.e1-4. PubMed ID: 20685314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition.
    Li Q; Sodroski C; Lowey B; Schweitzer CJ; Cha H; Zhang F; Liang TJ
    Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7620-5. PubMed ID: 27298373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single Particle Imaging of Polarized Hepatoma Organoids upon Hepatitis C Virus Infection Reveals an Ordered and Sequential Entry Process.
    Baktash Y; Madhav A; Coller KE; Randall G
    Cell Host Microbe; 2018 Mar; 23(3):382-394.e5. PubMed ID: 29544098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occludin-Knockout Human Hepatic Huh7.5.1-8-Derived Cells Are Completely Resistant to Hepatitis C Virus Infection.
    Shirasago Y; Shimizu Y; Tanida I; Suzuki T; Suzuki R; Sugiyama K; Wakita T; Hanada K; Yagi K; Kondoh M; Fukasawa M
    Biol Pharm Bull; 2016 May; 39(5):839-48. PubMed ID: 26887345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occludin stalls HCV particle dynamics apart from hepatocyte tight junctions, promoting virion internalization.
    Deffieu MS; Clément CMH; Dorobantu CM; Partiot E; Bare Y; Faklaris O; Rivière B; Ayala-Nunez NV; Baumert TF; Rondé P; Mély Y; Lucansky V; Gaudin R
    Hepatology; 2022 Oct; 76(4):1164-1179. PubMed ID: 35388524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of epidermal growth factor receptor, claudin-1 and occludin in multi-step entry of hepatitis C virus into polarized hepatoma spheroids.
    So CW; Sourisseau M; Sarwar S; Evans MJ; Randall G
    PLoS Pathog; 2023 Dec; 19(12):e1011887. PubMed ID: 38157366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel human anti-claudin 1 mAbs inhibit hepatitis C virus infection and may synergize with anti-SRB1 mAb.
    Paciello R; Urbanowicz RA; Riccio G; Sasso E; McClure CP; Zambrano N; Ball JK; Cortese R; Nicosia A; De Lorenzo C
    J Gen Virol; 2016 Jan; 97(1):82-94. PubMed ID: 26519290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human claudin-1-derived peptide inhibits hepatitis C virus entry.
    Si Y; Liu S; Liu X; Jacobs JL; Cheng M; Niu Y; Jin Q; Wang T; Yang W
    Hepatology; 2012 Aug; 56(2):507-15. PubMed ID: 22378192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.